James Edward Doyle, Director at EXACT SCIENCES CORP (EXAS), sold 2,970 shares at $42.02 ($125K) on 2025-08-13, disclosed to the SEC on 2025-08-14.
Scheduled sale ($125k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.02 | 1,485 | $62K | 50.0% |
| 2 | $42.02 | 1,485 | $62K | 50.0% |
| Total | $42.02 avg | 2,970 | $125K | 100% |
| Filing → |
| EXAS | SELL | 2023-07-28 | $195K | — | Filing → |
| EXAS | SELL | 2023-06-12 | $254K | — | Filing → |
| EXAS | SELL | 2023-05-31 | $161K | — | Filing → |